NIH-funded research R21 grant

Understanding how gut bacteria affect antibiotic resistance in children

Official title: Bacterial Community Barrier to Vancomycin Resistant Enterococcus

Funded at St. Jude Children's Research Hospital · NIH-11103176 · Data updated 2026-11-12

This study is looking at how the bacteria in the intestines of children with weakened immune systems can affect the growth of a harmful germ called vancomycin-resistant Enterococci (VRE), with the goal of finding ways to help prevent infections in these kids.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startJune 4, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$231,250
NIH project number5R21AI180489-02
Project IDNIH-11103176 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are immunocompromised children under the age of 11 who are at risk for infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients who are not immunocompromised or are older than 11 years may not benefit from this research.

What this research studies

This research investigates how the gut microbiome influences the colonization of vancomycin-resistant Enterococci (VRE) in immunocompromised children. It aims to identify specific bacteria in the intestines that can either promote or inhibit the growth of VRE. By using advanced molecular techniques and bioinformatics, the study will explore the interactions between these gut microbes and VRE, providing insights into how antibiotic resistance develops. The findings could lead to new strategies for preventing infections in vulnerable pediatric populations.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies against antibiotic-resistant infections in children.

How similar studies have gone: Other research has shown success in understanding the role of the microbiome in antibiotic resistance, making this approach promising.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Margolis, Elisa B H — St. Jude Children's Research Hospital
  • Study coordinator: Margolis, Elisa B H

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.